T0	Interventions 11 83	intravenous iron combined with low-dose recombinant human erythropoietin
T1	Interventions 244 309	parenteral iron and recombinant human erythropoietin-β (rHuEPO-β)
T2	Interventions 573 584	C (control)
T3	Interventions 594 668	IE (200 mg of iron sucrose intravenously over 1 hr and 3000 IU of rHuEPO-β
T4	Interventions 1678 1720	with parenteral iron and low-dose rHuEPO-β